|
FY2026
12 months to Jul 3, 2026
|
FY2025
12 months to Jun 27, 2025
|
|
|---|---|---|
| Revenue, net | ||
| Cost of revenue | ||
| Gross profit | ||
| Operating expenses: | ||
| Research and development | ||
| Selling, general and administrative | ||
| Goodwill impairment | ||
| Loss on debt extinguishment | ||
| Business separation costs | ||
| Employee termination and other | ||
| Total operating expenses | ||
| Operating income (loss) | ||
| Interest and other income (expense), net: | ||
| Gain (loss) on equity securities, net | ||
| Interest income | ||
| Interest expense | ||
| Other income (expense), net | ||
| Total interest and other income (expense), net | ||
| Income (loss) before taxes | ||
| Income tax expense | ||
| Net income (loss) | ||
| Net income (loss) per common share: | ||
| Basic (in dollars per share) | ||
| Diluted (in dollars per share) | ||
| Weighted average shares outstanding: | ||
| Basic (in shares) | ||
| Diluted (in shares) |
Loading...
